Effects of Left and Bilateral Transcutaneous Auricular Vagus Nerve Stimulation on Pain, Mood, and Autonomic Function in Female Fibromyalgia Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 2, 2021

Primary Completion Date

August 30, 2021

Study Completion Date

October 31, 2022

Conditions
Fibromyalgia Syndrome
Interventions
DEVICE

Transcutaneous Auricular Vagus Nerve Stimulation

taVNS was performed using the Vagustim device (Vagustim Health Technologies, Teknokent, Istanbul, Türkiye) at the tragus and concha regions for 30 minutes, with a frequency of 25 Hz and a pulse width of 300 µs in both groups. The difference in stimulation between the groups depends only on to which ear it was applied. Electrical stimulation was increased in 0.1 mA steps until the detection threshold was reached.

Trial Locations (1)

Unknown

Sancak Tıp Merkezi, Istanbul

All Listed Sponsors
lead

Fenerbahce University

OTHER

NCT06871306 - Effects of Left and Bilateral Transcutaneous Auricular Vagus Nerve Stimulation on Pain, Mood, and Autonomic Function in Female Fibromyalgia Patients | Biotech Hunter | Biotech Hunter